These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1506127)

  • 1. Presentation of results from bioequivalence studies.
    Sauter R; Steinijans VW; Diletti E; Böhm A; Schulz HU
    Int J Clin Pharmacol Ther Toxicol; 1992 Jul; 30(7):233-56. PubMed ID: 1506127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation of results from bioequivalence studies.
    Sauter R; Steinijans VW; Diletti E; Böhm A; Schulz HU
    Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S7-30. PubMed ID: 1601535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multiple-dose safety and bioequivalence study of a narrow therapeutic index drug: a case for carbamazepine.
    Yacobi A; Zlotnick S; Colaizzi JL; Moros D; Masson E; Abolfathi Z; LeBel M; Mehta R; Golander Y; Levitt B
    Clin Pharmacol Ther; 1999 Apr; 65(4):389-94. PubMed ID: 10223775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence studies: single vs multiple dose.
    Steinijans VW; Sauter R; Jonkman JH; Schulz HU; Stricker H; Blume H
    Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):261-6. PubMed ID: 2737794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single dose study of the bioequivalence of two sustained-release theophylline formulations.
    Contreras J; Pérez N; González R; Ontivero E; López M
    Arzneimittelforschung; 1998 Mar; 48(3):259-62. PubMed ID: 9553683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A distribution-free procedure for the statistical analysis of bioequivalence studies.
    Hauschke D; Steinijans VW; Diletti E
    Int J Clin Pharmacol Ther Toxicol; 1990 Feb; 28(2):72-8. PubMed ID: 2307548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A three-step procedure for assessing bioequivalence in the general mixed model framework.
    Vuorinen J; Turunen J
    Stat Med; 1996 Dec; 15(24):2635-55. PubMed ID: 8981677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A limited sampling approach in bioequivalence studies: application to long half-life drugs and replicate design studies.
    Mahmood I; Mahayni H
    Int J Clin Pharmacol Ther; 1999 Jun; 37(6):275-81. PubMed ID: 10395118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian modeling of multivariate average bioequivalence.
    Ghosh P; Gönen M
    Stat Med; 2008 Jun; 27(13):2402-19. PubMed ID: 18095275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of the intrasubject coefficient of variation for sample size planning in bioequivalence studies.
    Hauschke D; Steinijans WV; Diletti E; Schall R; Luus HG; Elze M; Blume H
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):376-8. PubMed ID: 7952801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reference tables for the intrasubject coefficient of variation in bioequivalence studies.
    Steinijans VW; Sauter R; Hauschke D; Diletti E; Schall R; Luus HG; Elze M; Blume H; Hoffmann C; Franke G
    Int J Clin Pharmacol Ther; 1995 Aug; 33(8):427-30. PubMed ID: 8556220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
    González MA; Straughan AB
    Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The availability of original data and statistics: an improvement in good publication practice.
    Morselli-Labate AM
    JOP; 2003 Nov; 4(6):193-9. PubMed ID: 14614199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic analysis of bioequivalence trials: implications for sex-related issues in clinical pharmacology and biopharmaceutics.
    Chen ML; Lee SC; Ng MJ; Schuirmann DJ; Lesko LJ; Williams RL
    Clin Pharmacol Ther; 2000 Nov; 68(5):510-21. PubMed ID: 11103754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPLC analysis of theophylline: bioequivalence study of two sustained-release formulations at steady state.
    Mazzei M; Sottofattori E; Balbi A; Bottino GB
    Farmaco; 1992 May; 47(5 Suppl):769-77. PubMed ID: 1524625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size determination for bioequivalence assessment by means of confidence intervals.
    Diletti E; Hauschke D; Steinijans VW
    Int J Clin Pharmacol Ther Toxicol; 1991 Jan; 29(1):1-8. PubMed ID: 2004861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size determination for bioequivalence assessment by means of confidence intervals.
    Diletti E; Hauschke D; Steinijans VW
    Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S51-8. PubMed ID: 1601532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma pooling to expedite bioequivalence estimation of rifampicin in fixed dose combinations.
    Panchagnula R; Parmar J; Kaur JK; Singh I; Bhade SR
    Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):161-7. PubMed ID: 16810342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence studies: single vs multiple dose.
    Steinijans VW; Sauter R; Jonkman JH; Schulz HU; Stricker H; Blume H
    Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S31-6. PubMed ID: 1601529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: linear kinetics (I).
    Fernández-Teruel C; Nalda Molina R; González-Alvarez I; Navarro-Fontestad C; García-Arieta A; Casabó VG; Bermejo M
    Eur J Pharm Sci; 2009 Jan; 36(1):137-46. PubMed ID: 19028574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.